Morimoto M - Search Results

1

Prediction model for pancreatic cancer risk in the general Japanese population.

Nakatochi M, Lin Y, Ito H, Hara K, Kinoshita F, Kobayashi Y, Ishii H, Ozaka M, Sasaki T, Sasahira N, Morimoto M, Kobayashi S, Ueno M, Ohkawa S, Egawa N, Kuruma S, Mori M, Nakao H, Wang C, Nishiyama T, Kawaguchi T, Takahashi M, Matsuda F, Kikuchi S, Matsuo K. Nakatochi M, et al. Among authors: morimoto m. PLoS One. 2018 Sep 7;13(9):e0203386. doi: 10.1371/journal.pone.0203386. eCollection 2018. PLoS One. 2018. PMID: 30192808 Free PMC article.

2

Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib.

Morimoto M, Numata K, Kondo M, Hidaka H, Takada J, Shibuya A, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K. Morimoto M, et al. Hepatol Res. 2011 Apr;41(4):296-302. doi: 10.1111/j.1872-034X.2011.00778.x. Epub 2011 Feb 23. Hepatol Res. 2011. PMID: 21348907

3

[Influence of body surface area on efficacy and safety of sorafenib in advanced hepatocellular carcinoma].

Kobayashi S, Ohkawa S, Kondo M, Morimoto M, Numata K, Matsunaga K, Okuse C, Suzuki M, Hidaka H, Takada J, Okuwaki Y, Shibuya A, Tanaka K. Kobayashi S, et al. Among authors: morimoto m. Gan To Kagaku Ryoho. 2012 Jul;39(7):1065-70. Gan To Kagaku Ryoho. 2012. PMID: 22790040 Japanese.

4

Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis.

Morimoto M, Numata K, Kondo M, Kobayashi S, Ohkawa S, Hidaka H, Nakazawa T, Okuwaki Y, Okuse C, Matsunaga K, Suzuki M, Morita S, Taguri M, Tanaka K. Morimoto M, et al. Hepatol Res. 2015 Mar;45(3):279-87. doi: 10.1111/hepr.12354. Epub 2014 May 28. Hepatol Res. 2015. PMID: 24802232

5

Renal toxicity associated with weekly cisplatin and gemcitabine combination therapy for treatment of advanced biliary tract cancer.

Kobayashi S, Ueno M, Ohkawa S, Irie K, Goda Y, Morimoto M. Kobayashi S, et al. Among authors: morimoto m. Oncology. 2014;87(1):30-9. doi: 10.1159/000362604. Epub 2014 Jun 25. Oncology. 2014. PMID: 24969038

6

Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for resected pancreatic cancer.

Aoyama T, Katayama Y, Murakawa M, Asari M, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Ohkawa S, Akaike M, Yamamoto N, Yoshikawa T, Rino Y, Masuda M, Morinaga S. Aoyama T, et al. Among authors: morimoto m. Cancer Chemother Pharmacol. 2014 Dec;74(6):1235-40. doi: 10.1007/s00280-014-2601-y. Epub 2014 Oct 9. Cancer Chemother Pharmacol. 2014. PMID: 25297990

7

Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.

Irie K, Morimoto M, Numata K, Kondo M, Moriya S, Shimoyama Y, Nozaki A, Goda Y, Kobayashi S, Ueno M, Ohkawa S, Tanaka K, Maeda S. Irie K, et al. Among authors: morimoto m. Abdom Imaging. 2015 Aug;40(6):1821-8. doi: 10.1007/s00261-014-0332-5. Abdom Imaging. 2015. PMID: 25526685

8

Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients.

Aoyama T, Katayama Y, Murakawa M, Atsumi Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Yamamoto N, Oshima T, Yoshikawa T, Rino Y, Masuda M, Morinaga S. Aoyama T, et al. Among authors: morimoto m. Cancer Chemother Pharmacol. 2015 Jun;75(6):1115-20. doi: 10.1007/s00280-015-2736-5. Epub 2015 Mar 29. Cancer Chemother Pharmacol. 2015. PMID: 25821166

9

Glasgow Prognostic Score Predicts Clinical Outcomes in Patients with Pancreatic Cancer Undergoing Adjuvant Gemcitabine Monotherapy After Curative Surgery.

Morinaga S, Murakawa M, Katayama Y, Yamaoku K, Aoyama T, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M. Morinaga S, et al. Among authors: morimoto m. Anticancer Res. 2015 Sep;35(9):4865-70. Anticancer Res. 2015. PMID: 26254380 Clinical Trial.

10

Potential prognostic significance of a new proteomic profile in patients with advanced pancreatic adenocarcinoma.

Kobayashi S, Ueno M, Irie K, Goda Y, Aoyama T, Morinaga S, Ohkawa S, Morimoto M. Kobayashi S, et al. Among authors: morimoto m. Pancreatology. 2015 Sep-Oct;15(5):525-530. doi: 10.1016/j.pan.2015.07.003. Epub 2015 Jul 29. Pancreatology. 2015. PMID: 26255025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,709 results

Search Page